Uni-Pex Pharmaceuticals Private Limited, a active private limited company, was established on 10 March 1999 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231DL1999PTC098759. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Jagdish Chand Bansal (Director), Madan Lal Bansal (Director). Past directors included Rajesh Bansal. It holds ₹1.75 Cr open charges and ₹20.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 801, 8Th Floor, Gopal Heights, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
U24231DL1999PTC098759
098759
10 March 1999
₹5.00 M
₹5.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Uni-Pex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagdish Chand Bansal | Director | 10 Mar 1999 | Current |
| Madan Lal Bansal | Director | 10 Mar 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Uni-Pex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.37% decrease. The company also saw a substantial fall in profitability, with a 56.54% decrease in profit. The company's net worth moved up by a moderate rise of 3.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Uni-Pex Pharmaceuticals had a public holding of 27.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹17,500,000.00
₹200,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2021 | Hdfc Bank Limited | ₹1.75 Cr | Open |
| 14 Sep 2022 | Hdfc Bank Limited | ₹20.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Uni-Pex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uni-Pex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni-Pex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Uni-Pex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge registered on 14 Sep 2022 via Charge ID 100621504 with Hdfc Bank Limited was fully satisfied on 02 Sep 2024. was recorded as a recent event.
Progress on Uni-Pex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 200.00 M with Charge ID 100621504 was registered on 14 Sep 2022. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 17.50 M with Charge ID 100531614 was registered on 23 Nov 2021. was documented.
Jagdish Chand Bansal was appointed as a Director was appointed as a Director on 10 Mar 1999 & has been associated with this company since 26 years 8 months . was recorded as a recent event.
The CIN of Uni-Pex Pharmaceuticals Private Limited is U24231DL1999PTC098759.
Uni-Pex Pharmaceuticals Private Limited is headquartered at 801, 8Th Floor, Gopal Heights, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.
Uni-Pex Pharmaceuticals Private Limited was incorporated on 10 March 1999.
The current directors of Uni-Pex Pharmaceuticals Private Limited are
The primary industry of Uni-Pex Pharmaceuticals Private Limited is Trade.
Uni-Pex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Uni-Pex Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Uni-Pex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX